Table 1.
Demographic and clinical data MTLE-NL patients with or without increased amygdala.
| Normal amygdala (n = 48) | Increased amygdala (n = 8) | p Value | |
|---|---|---|---|
| Sex | M = 26 | M = 1 | p = 0.081 (Pearson Chi-square) |
| Mean age (range) | 41.7 (19–74 years) | 47.6 (29–68 years) | p = 0.274 (t-test) |
| Mean age of seizure onset (range) | 19.8 (2–48 years) | 17.9 (8–47 years) | p = 0.702 (t-test) |
| Family history of epilepsy | 29 | 3 | p = 0.507 (Pearson Chi-square) |
| IPI (FS) | 12 (3) | 2 (0) | p = 0.78 (Pearson Chi-square) |
| SE | 1 | 0 | p = 0.708 (Pearson Chi-square) |
| Mean duration of epilepsy (range) | 21.9 (1–50 years) | 25.75 (15–48 years) | p = 0.144 (t-test) |
| Seizure remission | 12 (25%) | 1 (12.5%) | p = 0.585 (Pearson Chi-square) |
| Number of patients with SGTCS in the previous year | 11 (23%) | 1 (12.5%) | p = 0.657 (Pearson Chi-square) |
MTLE-NL, mesial temporal lobe epilepsy with normal MRI; M, male; IPI, initial precipitating injury; FS, febrile seizure; SE, status epilepticus; SGTCS, secondary generalized tonic-clonic seizures.